WJ-39

CAT: 0804-HY-162325-01Size: 5 mgDry Ice: NoHazardous: No
CAT#:0804-HY-162325-01Size:5 mg
Selected
PRICE
AVAILABILITY: InStock
24/48H Stock Items & 2 to 6 Weeks non Stock Items.
Product image 1
1 / 1
Description
WJ-39 is an orally active aldose reductase (AR) inhibitor. WJ-39 improves tubular damage in diabetic nephropathy rats by activating PINK1/Parkin signaling, promoting mitophagy, and attenuating apoptosis[1].
CAS Number
[3009908-95-3]
UNSPSC
12352005
Target
Aldose Reductase; Apoptosis; Mitochondrial Metabolism; Mitophagy
Type
Reference compound
Related Pathways
Apoptosis; Autophagy; Metabolic Enzyme/Protease
Applications
Metabolism-sugar/lipid metabolism
Field of Research
Metabolic Disease
Assay Protocol
https://www.medchemexpress.com/wj-39.html
Concentration
10mM
Purity
99.60
Solubility
DMSO : ≥ 350 mg/mL
Smiles
COC1=CC=C(N(CC(O[K])=O)C=C(CC2=CC=CC(Cl)=C2Cl)C3=O)C3=C1
Molecular Formula
C19H14Cl2KNO4
Molecular Weight
430.32
References & Citations
[1]Yang L, et al. An aldose reductase inhibitor, WJ-39, ameliorates renal tubular injury in diabetic nephropathy by activating PINK1/Parkin signaling. Eur J Pharmacol. 2024 Mar 15;967:176376.
Shipping Conditions
Room Temperature
Storage Conditions
4°C (Powder, protect from light)
Scientific Category
Reference compound1
Clinical Information
No Development Reported

Related Products

CatalogName
HY-P5672Maximin 39
HY-149473AChE-IN-39
HY-129314CM-39
HY-157107ICMT-IN-39
HY-157665HSD17B13-IN-39
HY-170389BChE-IN-39
HY-141659-01CMPD-39
HY-171038STAT3-IN-39
HY-160845HDAC6-IN-39
HY-149520HPK1-IN-39

Alternative Products

CatalogName
BUP03999-01WJ-39
E-PP-2003-01TIP-39 (39 mer)
5-02006TIP 39 (39 mer)
PE-101335-01TIP 39 (39 Mer) Peptide
M11317-01BIBS-39
MBS716246139 Antibody
MBS5757929TRAM 39
MBS5816470CI-39
E8ER1911-81Keratin 39
075-09PR-39

Popular Products